@article{7b83779d91344abb84ef9148d53a2c2c,
title = "Modeling Medicaid and Medicare Savings from Reduced Poverty and Disability to Promote Investment in Mental Health and Substance Use Interventions in the USA",
author = "Counts, {Nathaniel Z.} and Paul Gionfriddo and Chapman, {Richard H.}",
note = "Funding Information: Mr. Counts and Mr. Gionfriddo have no conflicts of interest to disclose. Dr. Chapman{\textquoteright}s employer, the Institute for Clinical and Economic Review, has received grants from the California Health Care Foundation and the Laura and John Arnold Foundation. ICER as an organization has received membership dues, which are not related to this work, from a variety of payer and life science companies (Aetna, AHIP, Allergan, Alnylam, Anthem, Astra Zeneca, Biogen, Blue Shield of CA, Boehringer-Ingelheim, Cambia Health Services, CVS, Editas, Express Scripts, Genentech/Roche, GSK, Harvard Pilgrim, Health Care Service Corporation, Health Partners, HealthFirst, J&J (Janssen), Kaiser Permanente, LEO, Mallinckrodt, Merck, Novartis, NPC, Premera, Prime Therapeutics, Regeneron, Sanofi, Spark Therapeutics, and United Healthcare).",
year = "2020",
month = oct,
day = "1",
doi = "10.1007/s40258-020-00568-7",
language = "English (US)",
volume = "18",
pages = "601--604",
journal = "Applied Health Economics and Health Policy",
issn = "1175-5652",
publisher = "Adis International Ltd",
number = "5",
}
